Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis

G. Lombardo, G. Lombardo, R. Spinella, P. Quattrocchi, L. Giannetto (Messina, Italy)

Source: Annual Congress 2009 - Inflammation and airways
Session: Inflammation and airways
Session type: Thematic Poster Session
Number: 2132
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Lombardo, G. Lombardo, R. Spinella, P. Quattrocchi, L. Giannetto (Messina, Italy). Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis. Eur Respir J 2009; 34: Suppl. 53, 2132

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum levels of IL-10 and IL-12p40 in pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 139s
Year: 2007

Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002

Serum IL-10 and IL-12 level changes in tuberculosis
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Interleukin-10 and interferon-gamma levels in blood serum in lung sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 332s
Year: 2005

Serum IL-12p70 and IL-12p40 levels in severe asthma patients with fixed airway obstruction
Source: Eur Respir J 2006; 28: Suppl. 50, 234s
Year: 2006

Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011


Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 556s
Year: 2002

Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level
Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis
Year: 2003


IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Increased IL-13 production in sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 314s
Year: 2002

TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Increased IL-16 production in sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 107s
Year: 2001

TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018


Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017